H. Lukka

发表

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

D. Low, H. Sandler, G. Rodrigues, 2022, The Lancet.

Prostate-specific antigen after neoadjuvant androgen suppression in prostate cancer patients receiving short-term androgen suppression and external beam radiotherapy: pooled analysis of four NRG Oncology RTOG randomized clinical trials

Hanks, E. Horwitz, T. Pisansky, 2019 .

Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601

A. Zietman, H. Sandler, R. Dess, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer.

G. Pond, A. Neville, S. Hotte, 2019, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP).

I. Kaplan, D. Beyer, H. Sandler, 2016 .

Salvage radiotherapy following HiFU: An institutional series and literature review

T. Tsakiridis, M. Goldberg, K. Quan, 2022, Journal of medical imaging and radiation oncology.

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

H. Sandler, P. Tran, F. Feng, 2021, JAMA oncology.

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

D. Grignon, A. Zietman, H. Sandler, 2017, The New England journal of medicine.

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

H. Sandler, M. Amin, T. Pisansky, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials.

H. Sandler, E. Horwitz, T. Pisansky, 2019, International journal of radiation oncology, biology, physics.

Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial

T. Whelan, E. Rakovitch, A. Fyles, 2023, Breast.

Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada.

C. Ménard, P. Warde, A. Berlin, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data.

C. Catton, É. Vigneault, J. Crook, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.

I. Kaplan, D. Beyer, H. Sandler, 2018, International journal of radiation oncology, biology, physics.

A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806).

L. Thabane, T. Tsakiridis, J. Cutz, 2020, Clinical genitourinary cancer.

The RADICAL-PC trial.

L. Klotz, P. Devereaux, D. Leong, 2016 .

Five-year patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer.

I. Kaplan, H. Sandler, E. Horwitz, 2022, International journal of radiation oncology, biology, physics.

Prognostic impact of PSA nadir (n) ≥0.1 ng/mL within 6 months (m) after completion of radiotherapy (RT) for localized prostate cancer (PCa): An individual patient-data (IPD) analysis of randomized trials from the ICECAP collaborative.

A. D'Amico, M. Sydes, D. Dearnaley, 2023, Journal of Clinical Oncology.